Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options. [electronic resource]
Producer: 20160530Description: 55-61 p. digitalISSN:- 1096-9098
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- analysis
- Carcinoma, Hepatocellular -- chemistry
- Erlotinib Hydrochloride -- administration & dosage
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
- Liver Neoplasms -- chemistry
- Lung Neoplasms -- secondary
- Male
- Middle Aged
- Molecular Targeted Therapy
- Mutation
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Phosphoinositide-3 Kinase Inhibitors
- Poly(ADP-ribose) Polymerase Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Retrospective Studies
- Sorafenib
- Tumor Suppressor Protein p53 -- genetics
- beta Catenin -- genetics
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.